# A Study of JNJ-61393215 in the Treatment of Depression

> **NCT04080752** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 222 (actual)

## Conditions studied

- Major Depressive Disorder With Anxious Distress

## Interventions

- **DRUG:** JNJ-61393215
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04080752
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-17
- **Primary completion:** 2021-09-02
- **Final completion:** 2021-09-02
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080752, "A Study of JNJ-61393215 in the Treatment of Depression". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04080752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*